Percutaneous nephrolithotomy (PCNL) has been a popular treatment option for kidney stones since its development in the 1970s. It is a minimally invasive procedure that involves making a small incision in the patient's back and inserting a tube into the kidney to remove the stone. The procedure has been successful in treating larger stones that cannot be treated with other methods, such as shockwave lithotripsy. However, PCNL has also been associated with a number of risks, including infection, bleeding, and pain. Recently, advances in technology have allowed for a new type of PCNL, known as Outpatient Ureteroscopy and Nephrolithotomy (OUSN). This procedure is less invasive than traditional PCNL and has a lower risk of complications. In this article, we will discuss the advantages of OUSN and how it is revolutionizing the treatment of kidney stones.
OUSN is a minimally invasive procedure that combines ureteroscopy and nephrolithotomy. Ureteroscopy is a procedure in which a flexible scope is inserted through the urethra and bladder into the ureter, the tube that connects the kidney to the bladder. Through this scope, the doctor can see the stone and remove it with a basket-like device. Nephrolithotomy is a procedure in which a small incision is made in the patient's back and a tube is inserted into the kidney to remove the stone. With OUSN, the ureteroscopy and nephrolithotomy are performed in one procedure, which reduces the risk of complications and allows for a shorter recovery time.
OUSN has several advantages over traditional PCNL. First, OUSN is less invasive than PCNL, which means it has a lower risk of complications. Additionally, OUSN does not require general anesthesia, which reduces the risk of anesthesia-related complications. Finally, OUSN has a shorter recovery time than PCNL, allowing patients to return to their normal activities sooner.
OUSN is becoming increasingly popular among doctors as a way to treat kidney stones. Studies have shown that OUSN is as effective as traditional PCNL in treating larger stones, but with fewer complications and a shorter recovery time. Additionally, OUSN is often less expensive than PCNL, making it a more cost-effective option.
OUSN is a revolutionary new procedure that is revolutionizing the treatment of kidney stones. It is less invasive than traditional PCNL and has a lower risk of complications and a shorter recovery time. Additionally, OUSN is often more cost-effective than PCNL. As OUSN becomes more widely available, it is likely to become the preferred method of treating kidney stones.
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
3.
New First-Line Option for Advanced ALK-Positive Lung Cancer
4.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
5.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
1.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
2.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
3.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
4.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
5.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
5.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation